Arax Advisory Partners Has $2.63 Million Stock Position in HCA Healthcare, Inc. $HCA

Arax Advisory Partners reduced its position in HCA Healthcare, Inc. (NYSE:HCA) by 40.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 5,638 shares of the company’s stock after selling 3,880 shares during the quarter. Arax Advisory Partners’ holdings in HCA Healthcare were worth $2,632,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in HCA. Palisade Asset Management LLC bought a new position in shares of HCA Healthcare during the third quarter valued at $26,000. Holos Integrated Wealth LLC acquired a new stake in shares of HCA Healthcare in the fourth quarter valued at $29,000. Ares Financial Consulting LLC bought a new position in shares of HCA Healthcare in the fourth quarter valued at about $31,000. JPL Wealth Management LLC bought a new position in shares of HCA Healthcare in the third quarter valued at about $33,000. Finally, Aventura Private Wealth LLC bought a new position in shares of HCA Healthcare in the fourth quarter valued at about $34,000. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Trading Up 0.0%

HCA Healthcare stock opened at $387.25 on Monday. The firm has a market capitalization of $85.91 billion, a P/E ratio of 13.32, a PEG ratio of 1.23 and a beta of 1.12. HCA Healthcare, Inc. has a 1 year low of $330.00 and a 1 year high of $556.52. The business has a 50-day moving average of $429.60 and a 200-day moving average of $473.29.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.19 by ($0.04). The company had revenue of $19.11 billion for the quarter, compared to analyst estimates of $19.09 billion. HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.HCA Healthcare’s quarterly revenue was up 4.3% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $6.45 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Research analysts anticipate that HCA Healthcare, Inc. will post 30.07 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th will be given a $0.78 dividend. The ex-dividend date is Tuesday, June 16th. This represents a $3.12 annualized dividend and a dividend yield of 0.8%. HCA Healthcare’s payout ratio is currently 10.73%.

Wall Street Analysts Forecast Growth

HCA has been the subject of a number of research analyst reports. Sanford C. Bernstein cut their price target on HCA Healthcare from $503.00 to $413.00 and set a “market perform” rating for the company in a report on Thursday, June 4th. Robert W. Baird cut their price target on HCA Healthcare from $450.00 to $442.00 and set a “neutral” rating for the company in a report on Wednesday, April 15th. Wall Street Zen lowered HCA Healthcare from a “buy” rating to a “hold” rating in a research report on Saturday, May 2nd. Leerink Partners lowered their price objective on HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating for the company in a research report on Monday, April 27th. Finally, Argus lowered their price objective on HCA Healthcare from $560.00 to $500.00 and set a “buy” rating for the company in a research report on Monday, May 4th. Fifteen research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, HCA Healthcare currently has an average rating of “Moderate Buy” and an average target price of $506.14.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.